SCHEMBL3497679

SCHEMBL3497679

CNC(=S)NNc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
GAA P10253 7/20 0.44
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.42
RAPGEF4 Q8WZA2 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MYC P01106 1/20 0.41
MAX P61244 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
IDO1 P14902 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10133740 0.81 MAPT (0.62) MAPTGAAALDH1A1NPSR1TDP1
SCHEMBL12197689 0.74 MAPT (0.53) MAPTGAAALDH1A1NPSR1TDP1
SCHEMBL8795017 0.73 MAPT (0.48) MAPTRAPGEF4IDO1
SCHEMBL11009249 0.72 MAPT (0.67) MAPTGAAALDH1A1NPSR1TDP1
SCHEMBL15481298 0.71 MAPT (0.56) MAPTGAAALDH1A1NPSR1TDP1
SCHEMBL13301012 0.69 MAPT (0.56) MAPTGAAALDH1A1NPSR1TDP1
SCHEMBL21652719 0.69 GAA (0.48) MAPTGAA
SCHEMBL330354 0.69 MAPT (0.55) MAPTALDH1A1RAPGEF4IDO1
SCHEMBL12412637 0.69 ALDH1A1 (0.76) MAPTGAAALDH1A1NPSR1TDP1
SCHEMBL10509816 0.68 MAPT (0.47) MAPTGAAALDH1A1NPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed